Policy

The 8th ABC International Consensus Conference (ABC8), Lisbon 2025 Over the past decade, the landscape of advanced breast cancer has changed more rapidly than at any time since systemic therapy became standard. New drug classes, more refined biomarkers, and increasingly…

European cancer policy has entered a decisive phase. After years of strategy-building, consultation, and pilot projects, the question facing policymakers is no longer whether Europe has the right ambitions, but whether it can turn those ambitions into sustainable systems that…

Across the EU, cancer inequalities are stark along the entire care pathway – prevention, screening and early detection, diagnosis and treatment, and survivorship care. HPV vaccination rates remain far below the 90% target in most countries; colorectal cancer screening ranges…

Interview with Olivér Várhelyi, EU Commissioner for Health and Animal Welfare Image Credits:  European Union 2025 - Source: European Parliament  Cancer remains one of Europe’s most significant public health challenges, with incidence rising and inequalities in prevention, diagnosis, and care…

When he enters the bazaar, people stand up… They stop. They smile. They love him.  This kind of love has nothing to do with titles, resources, or power. It is something far rarer. It is the quiet admiration of ordinary…

He is passionate about the mission of UICC. *** When Cary Adams tells the story of how his career began, it doesn’t start with a calling in oncology. It starts with a teenage conversation about what might matter in the…

When Dr. Hosams Abu Meri walks into a clinic room in Latvia, patients see something very unusual. The person doing their gastroscopy or colonoscopy is not only a gastroenterologist, he is also the Minister of Health of the Republic of…

I expected to meet a Minister defined by data, evidence and pragmatism. And I did. What I did not anticipate was the depth of empathy behind those qualities, or the disarming honesty of someone who describes himself, with a smile,…

Since joining the European Parliament in 2018, Tilly Metz has emerged as one of the most prominent voices in European health and cancer policy. Representing Luxembourg for the Greens/EFA group, she has played a central role in advancing the EU’s…

Across the European Union, cancer patients often wait months, or even years, for access to promising new treatments already approved by the EMA. Now, the EU’s new Health Technology Assessment (HTA) Regulation is introducing a shared framework for evaluating new…